363 related articles for article (PubMed ID: 27933676)
21. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
22. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease.
Skouras S; Falcon C; Tucholka A; Rami L; Sanchez-Valle R; Lladó A; Gispert JD; Molinuevo JL
Neuroimage Clin; 2019; 22():101777. PubMed ID: 30913531
[TBL] [Abstract][Full Text] [Related]
24. Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research Framework.
Devanarayan P; Devanarayan V; Llano DA;
J Alzheimers Dis; 2019; 68(2):537-550. PubMed ID: 30775985
[TBL] [Abstract][Full Text] [Related]
25. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
Hohman TJ; Bell SP; Jefferson AL;
JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal complex atrophy in poststroke and mild cognitive impairment.
Selnes P; Grambaite R; Rincon M; Bjørnerud A; Gjerstad L; Hessen E; Auning E; Johansen K; Almdahl IS; Due-Tønnessen P; Vegge K; Bjelke B; Fladby T
J Cereb Blood Flow Metab; 2015 Nov; 35(11):1729-37. PubMed ID: 26036934
[TBL] [Abstract][Full Text] [Related]
27. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
[TBL] [Abstract][Full Text] [Related]
28. CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy.
Herukka SK; Pennanen C; Soininen H; Pirttilä T
J Alzheimers Dis; 2008 May; 14(1):51-7. PubMed ID: 18525127
[TBL] [Abstract][Full Text] [Related]
29. Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment.
Ten Kate M; Barkhof F; Visser PJ; Teunissen CE; Scheltens P; van der Flier WM; Tijms BM
Alzheimers Res Ther; 2017 Sep; 9(1):73. PubMed ID: 28899429
[TBL] [Abstract][Full Text] [Related]
30. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
Marizzoni M; Ferrari C; Macis A; Jovicich J; Albani D; Babiloni C; Cavaliere L; Didic M; Forloni G; Galluzzi S; Hoffmann KT; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Pizzini F; Rossini PM; Salvatore M; Schönknecht P; Soricelli A; Del Percio C; Hensch T; Hegerl U; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
J Alzheimers Dis; 2019; 69(1):49-58. PubMed ID: 30958351
[TBL] [Abstract][Full Text] [Related]
31. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.
Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T
J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal change of biomarkers in cognitive decline.
Lo RY; Hubbard AE; Shaw LM; Trojanowski JQ; Petersen RC; Aisen PS; Weiner MW; Jagust WJ;
Arch Neurol; 2011 Oct; 68(10):1257-66. PubMed ID: 21670386
[TBL] [Abstract][Full Text] [Related]
34. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
[TBL] [Abstract][Full Text] [Related]
35. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.
Paterson RW; Bartlett JW; Blennow K; Fox NC; ; Shaw LM; Trojanowski JQ; Zetterberg H; Schott JM
Transl Psychiatry; 2014 Jul; 4(7):e419. PubMed ID: 25072324
[TBL] [Abstract][Full Text] [Related]
37. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
[TBL] [Abstract][Full Text] [Related]
38. White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm.
Tubi MA; Feingold FW; Kothapalli D; Hare ET; King KS; Thompson PM; Braskie MN;
Neuroimage; 2020 Feb; 206():116327. PubMed ID: 31682983
[TBL] [Abstract][Full Text] [Related]
39. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease.
Tarawneh R; Head D; Allison S; Buckles V; Fagan AM; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2015 Jun; 72(6):656-65. PubMed ID: 25867677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]